In medicine, an embolism occurs when an object (the embolus, plural emboli) migrates from one part of the body (through circulation) and causes a blockage of a blood vessel in another part of the body. Blood clots form a common embolic material. Other possible embolic materials include fat globules (a fat embolism), air bubbles (an air embolism), septic emboli (containing pus and bacteria), or amniotic fluid. Emboli often have more serious consequences when they occur in the so-called “end-circulation” areas of the body that have no redundant blood supply, such as the brain, heart, and lungs. Assuming normal circulation, a thrombus or other embolus formed in a systemic vein will always impact in the lungs, after passing through the right side of the heart. This forms a pulmonary embolism that can be a complication of deep-vein thrombosis.
Embolism can be contrasted with a “thrombus” which is the formation of a clot within a blood vessel, rather than being carried from elsewhere. Thrombus, or blood clot, is the final product of the blood coagulation step in hemostasis. It is achieved via the aggregation of platelets that form a platelet plug, and the activation of the humoral coagulation system (i.e., clotting factors). A thrombus is physiologic in cases of injury, but pathologic in case of thrombosis. A thrombus in a large blood vessel will decrease blood flow through that vessel. In a small blood vessel, blood flow may be completely cut-off resulting in the death of tissue supplied by that vessel. If a thrombus dislodges and becomes free-floating, it becomes an embolus.
Some of the conditions in which blood clots develop include atrial fibrillation (a form of cardiac arrhythmia), heart valve replacement, a recent heart attack, extended periods of inactivity (see deep venous thrombosis), and genetic or disease-related deficiencies in the blood's clotting abilities.
Preventing blood clots reduces the risk of stroke, heart attack and pulmonary embolism. Heparin and warfarin are often used to inhibit the formation and growth of existing blood clots, thereby allowing the body to shrink and dissolve the blood clots through normal methods (see anticoagulant). Regulating fluid flow through catheters can help minimize embolism and health risks associated therewith.
One aspect of the present invention discloses a medical device comprising a diaphragm having at least one slit valve disposed therein and at least one valve control member. The term “diaphragm,” as used herein, can be defined as any membranous part that divides or separates. The valve control member can be configured to cover at least a portion of the diaphragm without covering any portion of the slit valve and can be further configured to control deflection of the diaphragm. In another aspect of the invention, the valve control member comprises at least one arm extending from an outer portion of the valve control member to an inner portion of the valve control member. In still another aspect of the invention, the valve control member comprises a plurality of arms extending from an outer portion of the valve control member to a center portion of the valve control member. Further, the medical device can comprise a valve housing having the diaphragm therein, the valve housing being configured to be attached to an elongated tubular member, the elongated tubular member configured for at least partial placement into a portion of a patient. In another aspect of the invention, at least a portion of the slit valve has a nonlinear orientation. In another aspect of the invention the slit valve further comprises a plurality of interconnected linear slits oriented in different directions.
In another embodiment, a medical device for regulating fluid flow comprises a diaphragm having a slit valve disposed therein and a valve housing configured to secure the diaphragm at a peripheral portion of the diaphragm. A distal end of the valve housing can be further configured to attach to a proximal end of an elongated tubular member, such as a catheter. A central portion of the diaphragm is positioned relative to the peripheral portion of the diaphragm such that compressive forces acting on the peripheral portion of the diaphragm create moment forces which bias the slit valve in a neutral position. In one aspect of the invention, an outer portion of the diaphragm is thicker than an inner portion of the diaphragm. Alternatively, in another aspect of the invention, an outer portion of the diaphragm is thinner than an inner portion of the diaphragm. In still another aspect of the invention, the diaphragm may be substantially circular or substantially oval. In an additional embodiment of the invention, at least a portion of the diaphragm approximates the shape of a dome structure. In one aspect, the diaphragm further comprises a concave or convex annular member which circumscribes the dome structure. In one embodiment, the diaphragm is oriented substantially perpendicular to a direction of flow through the valve housing. In another embodiment, the diaphragm is oriented at an obtuse angle relative to a direction of flow through the valve housing. In one aspect, the diaphragm narrows from a lateral portion of the diaphragm to an opposite lateral portion of the diaphragm. In still another aspect, at least two slit valves are installed on opposing sides of the diaphragm.
In another embodiment, the diaphragm of the medical device further comprises at least one protruding member on a proximal end of the diaphragm configured to assist the slit valve to return to the biased neutral position. In one aspect, the diaphragm further comprises a pair of centrally located opposing protruding members on a proximal end of the diaphragm configured to assist the slit valve to return to the biased neutral position.
One embodiment of the invention contemplates a medical device comprising a diaphragm with at least one slit valve disposed therein. The proximal surface and distal surface of the diaphragm approximate a dome structure. The diaphragm is configured such that a portion of the proximal end of the diaphragm contiguous with the slit valve is thinner than an adjacent portion of the diaphragm. In one aspect, the diaphragm is secured at a peripheral portion by a valve housing, a distal end of the valve housing being configured to attach to a proximal portion of an elongated tubular member. In another aspect, the height of the peripheral portion of the diaphragm is greater than the height of the dome structure of the diaphragm at the apex of the dome structure of the diaphragm. In yet another aspect, the height of the peripheral portion of the diaphragm is approximately twice the width of the peripheral portion of the diaphragm. In another embodiment, the peripheral portion of the diaphragm is compressed by the valve housing approximately five to 15 percent. In another embodiment, a central portion of the diaphragm is subjected to moment forces from compression of the peripheral portion of the diaphragm thereby biasing the slit valve in a neutral position. In still another embodiment, a central portion of the diaphragm is positioned at a proximal end of the peripheral portion of the diaphragm.
In another embodiment of the present invention, a medical device comprises a cylindrical member having a proximal end configured to be secured at a peripheral portion by a valve housing, wherein the peripheral portion has a circumference greater than the circumference of the main cylindrical member. The medical device further comprises at least one slit valve placed on an outer wall of the cylindrical member. The slit valve is oriented parallel to a longitudinal axis of the cylindrical member. In one aspect, a distal end of the valve housing is configured to attach to a proximal end of an elongated tubular member, wherein a distal portion of the elongated tubular member is configured to be placed within a portion of a patient.
In a further embodiment, a medical device comprises a pressure-activated valve having an open circular proximal end and an at least partially closed distal end. The medical device is further configured such that the distal end comprises at least a partially planar surface having at least two slits oriented in different directions disposed therein. The slits have at least one common intersection and are configured to actuate in a distal direction in response to a first pressure differential. The medical device is further configured such that a portion of the distal end of the valve is defined by an interior angle of the intersecting slits, an outer portion of the distal end of the valve tapering from the distal end of the valve towards the proximal end of the valve thereby forming a channel on the outer portion of the distal end of the valve. In one aspect, the medical device further comprises at least one proximal-actuating slit valve installed on the distal end. The slit valve is configured to actuate in a proximal direction in response to a second pressure differential. In this aspect, the second pressure differential is greater than the first pressure differential. In another aspect, the slits placed in the distal end of the valve are oriented to approximate the shape of a cruciform thereby separating the distal end of the valve into quadrants. In one aspect, the valve is further configured such that the center of the cruciform is approximately collinear with the center of the circular proximal end of the valve. In yet another aspect, the at least one proximal-actuating slit valve is placed in a bottom portion of the channel.
In an additional embodiment, a method is disclosed comprising the steps of placing a distal end of a catheter into a vasculature of a patient, wherein a proximal end of the catheter has a medical device connected thereto. The medical device comprises a diaphragm having at least one slit valve disposed therein and a valve housing configured to secure the diaphragm at a peripheral portion of the diaphragm. A central portion of the diaphragm is positioned relative to the peripheral portion of the diaphragm such that compressive forces acting on the peripheral portion of the diaphragm create moment forces which bias the slit valve in a neutral position. The method further comprises the steps of creating a first liquid pressure differential across the slit valve thereby infusing liquids into the patient and creating a second pressure differential across the slit valve thereby aspirating liquids from a patient.
Features from any of the above-mentioned embodiments may be used in combination with one another in accordance with the instant disclosure. In addition, other features and advantages of the instant disclosure will become apparent to those of ordinary skill in the art through consideration of the ensuing description, the accompanying drawings, and the appended claims.
Advantages of the present invention will become apparent upon review of the following detailed description and drawings, which illustrate representations (not necessarily drawn to scale) of various embodiments of the invention, wherein:
One aspect of the instant disclosure relates to apparatuses and systems for pressure-activated valves for use with a medical device. Specifically, the instant disclosure contemplates that a slit valve may be disposed within a medical device, such as a catheter, for selective infusion and aspiration of fluids through the catheter and into a patient.
Referring to
In one embodiment, fluid may be delivered via catheter assembly 10 to patient 25 via an IV bag connected to a proximal portion of the catheter assembly 10 wherein the fluid is substantially gravity-fed to the patient 25. In another embodiment, fluids may be power injected via the catheter assembly 10 to the patient 25 by connecting a proximal portion of the second portion 40 of the catheter assembly 10 to a power injection system. In another aspect of the invention, fluids may be aspirated by connecting a syringe to the fluid removal location 44 and applying negative pressure to the catheter assembly 10.
Generally, one aspect of the invention contemplates a pressure-activated valve positioned in the flow path of a catheter inserted into a patient. The valve can be actuated in a distal direction by a first pressure differential, for example, gravity-induced pressure from a fluid source, such as an IV bag. The valve can also be actuated in a distal direction, for example, by power injection of contrast media into the patient. The valve can also be actuated in a proximal direction by a second pressure differential, for example, by negative pressure from a syringe thereby enabling blood withdrawal from the patient. In one embodiment, the first pressure differential is less than the second pressure differential. However, any of the pressure-activated valves disclosed herein can be reversed thereby changing the pressure differential paradigm (e.g., the first pressure differential is greater than the second pressure differential).
Referring now to
In one aspect of the invention, the valve control member 55 comprises at least one arm 60 extending from an outer portion 65 of the valve control member 55 to an inner portion 66 of the valve control member 55. In this aspect of the invention, the arm can extend laterally across a portion of the face of the diaphragm or any other angular orientation. In another embodiment, the valve control member 55 comprises a plurality of arms 60 extending from an outer portion 65 of the valve control member 55 to a center portion 66 of the valve control member 55. In one embodiment, a single slit valve 50 is disposed substantially within the center 75 of the diaphragm 45 and is substantially linear. In another embodiment several slit valves may be disposed either centrally or about the periphery of the diaphragm. Additionally, the slit valves may have a nonlinear orientation or may comprise a plurality of interconnected linear slits oriented in different directions.
Referring now to
As illustrated in
Referring now to
Referring generally to
In another embodiment, the diaphragm 155 further comprises at least one arm or protrusion 210. The protrusion 210 may be placed on a proximal end of the diaphragm 155 to assist the slit valve 160 to return to a neutral position after aspiration. When the slit valve 160 opens during aspiration, the protrusion 210 contacts the valve housing 150 thereby creating a moment force opposite the direction of contact to assist the slit valve 160 to return to a neutral position after aspiration. Multiple protrusions may be added in different embodiments on both distal and/or proximal ends of the diaphragm 155 to optimize valve function.
In another embodiment, the diaphragm 155 is configured such that a portion of the proximal end of the diaphragm contiguous with the slit valve is thinner than an adjacent portion of the diaphragm. The thinner area 215 near the slit valve 160 assists in actuation of slit valve 160 as well as slit valve performance during gravity flow of fluids through the diaphragm 155. In areas where the diaphragm is thinner, the diaphragm may be reinforced as illustrated in
As illustrated in
Referring to
Referring now to
Referring now to
Referring now to
Referring generally to
The diaphragms discussed herein can be molded in one piece from an elastomeric material (e.g., a silicone rubber having a Shore A Durometer rating from about 30 to 60). It should be noted that any of the diaphragms discussed herein can be manufactured from any elastomeric material including, without limitation, polyisoprene, butyl rubber, halogenated butyl rubbers, polybutadiene, styrene-butadiene rubber, nitrile rubber, hydrated nitrile rubbers, Therban® elastomer, Zetpol® elastomer, chloroprene rubber, polychloroprene, neoprene, baypren, EPM (ethylene propylene rubber, a copolymer faeces of polyethylene and polypropylene), EPDM rubber (ethylene propylene diene rubber, a terpolymer of polyethylene, polypropylene and a diene-component), epichlorohydrin rubber, polyacrylic rubber, fluorosilicone rubber, fluoroelastomers, Viton® elastomer, Tecnoflon® elastomer, Fluorel® elastomer, Dai-El® elastomer, perfluoroelastomers, tetrafluoro ethylene/propylene rubbers, chlorosulfonated polyethylene, Hypalon® elastomer, ethylene-vinyl acetate, Hytrel® elastomer, Santoprene® elastomer, polyurethane rubber, resilin, elastin, and/or Polysulfide rubber.
The valve housings discussed herein can be molded in one or more pieces from a thermoplastic material (e.g., a polyethylene terephthalate having a Shore A Durometer rating from about 60 to 85). It should be noted that any of the valve housings discussed herein can be manufactured from any thermoplastic material including, without limitation, acrylonitrile butadiene styrene, acrylic, celluloid, cellulose acetate, ethylene-vinyl acetate, ethylene vinyl alcohol, fluoroplastics, ionomers, polyacetal, polyacrylates, polyacrylonitrile, polyamide, polyamide-imide polyaryletherketone, polybutadiene, polybutylene, polybutylene terephthalate, polyethylene terephthalate, polycyclohexylene dimethylene terephthalate, polycarbonate, polyhydroxyalkanoates, polyketone, polyester, polyethylene, polyetheretherketone, polyetherimide, polyethersulfone, polyethylenechlorinates, polyimide, polylactic acid, polymethylpentene, polyphenylene oxide, polyphenylene sulfide, polyphthalamide, polypropylene, polystyrene, polysulfone, and/or polyvinyl chloride.
Any of the catheters described herein can be manufactured from any biocompatible material suitable for placement into a portion of a patient.
Although the above-described embodiments show a particular configuration of a pressure-actuated valve and valve assembly, such embodiments are exemplary. Accordingly, many different embodiments are contemplated and encompassed by this disclosure. It should also be understood that the device and method for controlling fluid flow through a catheter can be used with any method or device wherein fluids are administered to or removed from a patient.
While certain embodiments and details have been included herein for purposes of illustrating aspects of the instant disclosure, it will be apparent to those skilled in the art that various changes in the systems, apparatuses, and methods disclosed herein may be made without departing from the scope of the instant disclosure, which is defined, in part, in the appended claims. The words “including” and “having,” as used herein including the claims, shall have the same meaning as the word “comprising.”
This application claims the benefit of U.S. Provisional Application No. 60/741,578, entitled “PRESSURE-ACTIVATED PROXIMAL VALVES,” filed Dec. 2, 2005, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
274447 | Kennish | Mar 1883 | A |
856270 | Lewis | Jun 1907 | A |
966137 | Storey et al. | Aug 1910 | A |
2629393 | Langdon | Feb 1953 | A |
2896661 | Becker | Jul 1959 | A |
2941544 | Peras | Jun 1960 | A |
3007527 | Nelson | Nov 1961 | A |
3151626 | Everett | Oct 1964 | A |
3155110 | Hoffman | Nov 1964 | A |
3176712 | Ramsden | Apr 1965 | A |
3245428 | Klimak | Apr 1966 | A |
3275291 | Meijers | Sep 1966 | A |
3298391 | Savage | Jan 1967 | A |
3504669 | Albert | Apr 1970 | A |
3566913 | Parthe, Jr. | Mar 1971 | A |
3620500 | Santomieri | Nov 1971 | A |
3717177 | Glesmann | Feb 1973 | A |
3759249 | Fletcher et al. | Sep 1973 | A |
3770009 | Miller | Nov 1973 | A |
3811466 | Ohringer | May 1974 | A |
3822720 | Souza | Jul 1974 | A |
3848579 | Villa-Real | Nov 1974 | A |
3861412 | Fleischmann | Jan 1975 | A |
3897682 | Brooks | Aug 1975 | A |
3906930 | Guerra | Sep 1975 | A |
3941149 | Mittleman | Mar 1976 | A |
3960142 | Elliott et al. | Jun 1976 | A |
3991768 | Portnoy | Nov 1976 | A |
3996923 | Guerra | Dec 1976 | A |
4003398 | Duveau | Jan 1977 | A |
4044763 | Bird | Aug 1977 | A |
4103686 | LeFevre | Aug 1978 | A |
4127123 | Bird | Nov 1978 | A |
4134424 | Zeyra et al. | Jan 1979 | A |
4143853 | Abramson | Mar 1979 | A |
4197735 | Munzer et al. | Apr 1980 | A |
4244379 | Smith | Jan 1981 | A |
4341239 | Atkinson | Jul 1982 | A |
4342315 | Jackson | Aug 1982 | A |
4367767 | Hurd | Jan 1983 | A |
4387879 | Tauschinski | Jun 1983 | A |
4401116 | Fry et al. | Aug 1983 | A |
4417567 | Trick | Nov 1983 | A |
4430081 | Timmermans | Feb 1984 | A |
4434810 | Atkinson | Mar 1984 | A |
4436519 | O'Neill | Mar 1984 | A |
4439182 | Huang | Mar 1984 | A |
4470412 | Nowacki et al. | Sep 1984 | A |
4475898 | Brodner et al. | Oct 1984 | A |
4487207 | Fitz | Dec 1984 | A |
4487606 | Leviton et al. | Dec 1984 | A |
4510805 | Saint-Amour | Apr 1985 | A |
4512766 | Vailancourt | Apr 1985 | A |
4520819 | Birmingham et al. | Jun 1985 | A |
4533347 | Deckert | Aug 1985 | A |
4535818 | Duncan et al. | Aug 1985 | A |
4535819 | Atkinson et al. | Aug 1985 | A |
4542740 | Kleinschmidt et al. | Sep 1985 | A |
4549879 | Groshong et al. | Oct 1985 | A |
4553686 | Dougherty | Nov 1985 | A |
4566493 | Edwards et al. | Jan 1986 | A |
4568337 | Treharne, III et al. | Feb 1986 | A |
4576035 | Hooven et al. | Mar 1986 | A |
4608042 | Vanderveen et al. | Aug 1986 | A |
4610275 | Beecher | Sep 1986 | A |
4610469 | Wolff-Mooij | Sep 1986 | A |
4626245 | Weinstein | Dec 1986 | A |
4634027 | Kanarvogel | Jan 1987 | A |
4640277 | Meyer et al. | Feb 1987 | A |
4651730 | von dem Hagen et al. | Mar 1987 | A |
4671796 | Groshong et al. | Jun 1987 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4674526 | Athanassiu | Jun 1987 | A |
4698075 | Dechene | Oct 1987 | A |
4701166 | Groshong et al. | Oct 1987 | A |
4713054 | Kelly et al. | Dec 1987 | A |
4722725 | Sawyer | Feb 1988 | A |
4752287 | Kurtz et al. | Jun 1988 | A |
4769017 | Fath et al. | Sep 1988 | A |
4770170 | Sato et al. | Sep 1988 | A |
4784175 | Hicks | Nov 1988 | A |
4838261 | von dem Hagen | Jun 1989 | A |
4865583 | Tu | Sep 1989 | A |
4867741 | Portnoy | Sep 1989 | A |
4895565 | Hillstead | Jan 1990 | A |
4904245 | Chen et al. | Feb 1990 | A |
4930535 | Rinehold | Jun 1990 | A |
4932633 | Johnson et al. | Jun 1990 | A |
4946448 | Richmond | Aug 1990 | A |
4949448 | Hebnes | Aug 1990 | A |
4960412 | Fink | Oct 1990 | A |
4966137 | Davini | Oct 1990 | A |
4968294 | Salama | Nov 1990 | A |
4972929 | Ivers et al. | Nov 1990 | A |
4973319 | Melsky | Nov 1990 | A |
4995863 | Nichols et al. | Feb 1991 | A |
5000745 | Guest et al. | Mar 1991 | A |
5025829 | Edwards et al. | Jun 1991 | A |
5030210 | Alchas | Jul 1991 | A |
5038621 | Stupecky | Aug 1991 | A |
5041095 | Littrell | Aug 1991 | A |
5062448 | Hilsenbeck | Nov 1991 | A |
5064416 | Newgard | Nov 1991 | A |
5071411 | Hillstead et al. | Dec 1991 | A |
5085635 | Cragg | Feb 1992 | A |
5098393 | Amplatz et al. | Mar 1992 | A |
5113911 | Hirsh | May 1992 | A |
5125903 | McLaughlin et al. | Jun 1992 | A |
5135489 | Jepson et al. | Aug 1992 | A |
5141029 | Naugle et al. | Aug 1992 | A |
5141498 | Christian | Aug 1992 | A |
5147313 | Dikeman | Sep 1992 | A |
5147332 | Moorehead | Sep 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5154701 | Cheer et al. | Oct 1992 | A |
5156600 | Young | Oct 1992 | A |
5160325 | Nichols et al. | Nov 1992 | A |
5167615 | East et al. | Dec 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5169393 | Moorehead et al. | Dec 1992 | A |
5176652 | Littrell | Jan 1993 | A |
5201722 | Moorehead et al. | Apr 1993 | A |
5201725 | Kling | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5224938 | Fenton, Jr. | Jul 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5261459 | Atkinson et al. | Nov 1993 | A |
5269763 | Boehmer et al. | Dec 1993 | A |
5279587 | Weenig | Jan 1994 | A |
5290263 | Wigness et al. | Mar 1994 | A |
5295658 | Atkinson et al. | Mar 1994 | A |
5301707 | Hofsteenge | Apr 1994 | A |
5312363 | Ryan et al. | May 1994 | A |
5396925 | Poli | Mar 1995 | A |
5402982 | Atkinson et al. | Apr 1995 | A |
5409463 | Thomas et al. | Apr 1995 | A |
5411491 | Goldhardt et al. | May 1995 | A |
5453097 | Paradis | Sep 1995 | A |
5549565 | Ryan et al. | Aug 1996 | A |
5660200 | Paes | Aug 1997 | A |
5727594 | Choksi | Mar 1998 | A |
5730336 | Lerner | Mar 1998 | A |
5771935 | Myers | Jun 1998 | A |
5784999 | Larson et al. | Jul 1998 | A |
5800339 | Salama | Sep 1998 | A |
5807349 | Person et al. | Sep 1998 | A |
5833671 | Macoviak et al. | Nov 1998 | A |
5843044 | Moorehead | Dec 1998 | A |
5853397 | Shemesh et al. | Dec 1998 | A |
5858007 | Fagan et al. | Jan 1999 | A |
5984902 | Moorehead | Nov 1999 | A |
6024729 | Dehdashtian et al. | Feb 2000 | A |
6059757 | Macoviak et al. | May 2000 | A |
6322541 | West et al. | Nov 2001 | B2 |
6428520 | Lopez et al. | Aug 2002 | B1 |
6530504 | Socier | Mar 2003 | B2 |
6632200 | Potter et al. | Oct 2003 | B2 |
6923822 | Crawford et al. | Aug 2005 | B2 |
7004931 | Hogendijk | Feb 2006 | B2 |
7037303 | Beaufore et al. | May 2006 | B2 |
7044150 | Seidl | May 2006 | B2 |
7252652 | Moorehead et al. | Aug 2007 | B2 |
7435236 | Weaver et al. | Oct 2008 | B2 |
7491192 | DiFiore | Feb 2009 | B2 |
7540851 | O'Mahony et al. | Jun 2009 | B2 |
7601141 | Dikeman et al. | Oct 2009 | B2 |
20020010425 | Guo et al. | Jan 2002 | A1 |
20020010488 | Crawford et al. | Jan 2002 | A1 |
20020026139 | Bertrand et al. | Feb 2002 | A1 |
20020156430 | Haarala et al. | Oct 2002 | A1 |
20030111122 | Horton | Jun 2003 | A1 |
20040003846 | Seidl | Jan 2004 | A1 |
20040102738 | Dikeman et al. | May 2004 | A1 |
20040144435 | Dark | Jul 2004 | A1 |
20040176743 | Morris et al. | Sep 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20040193118 | Bergeron | Sep 2004 | A1 |
20040193119 | Canaud et al. | Sep 2004 | A1 |
20050027261 | Weaver et al. | Feb 2005 | A1 |
20050049555 | Moorehead et al. | Mar 2005 | A1 |
20050171488 | Weaver et al. | Aug 2005 | A1 |
20050171489 | Weaver et al. | Aug 2005 | A1 |
20050171490 | Weaver et al. | Aug 2005 | A1 |
20050171510 | DiCarlo et al. | Aug 2005 | A1 |
20050257837 | Bailey | Nov 2005 | A1 |
20050261725 | Crawford et al. | Nov 2005 | A1 |
20050267487 | Christensen et al. | Dec 2005 | A1 |
20060037975 | Suffa | Feb 2006 | A1 |
20060145116 | Rickerd et al. | Jul 2006 | A1 |
20060149214 | Breiter et al. | Jul 2006 | A1 |
20060212003 | Fangrow, Jr. | Sep 2006 | A1 |
20060224127 | Fangrow, Jr. | Oct 2006 | A1 |
20060276751 | Haberland et al. | Dec 2006 | A1 |
20070233007 | Adams | Oct 2007 | A1 |
20090043261 | Weaver et al. | Feb 2009 | A1 |
20090177187 | Quigley et al. | Jul 2009 | A1 |
20100036328 | Dikeman et al. | Feb 2010 | A1 |
Number | Date | Country |
---|---|---|
1052659 | Apr 1979 | CA |
03326696 | Jun 1984 | DE |
85308118 | Nov 1985 | EP |
89311584 | Nov 1989 | EP |
1954343 | Aug 2008 | EP |
966137 | Aug 1964 | GB |
2217433 | Dec 1988 | GB |
52118356 | Oct 1977 | JP |
52118357 | Oct 1977 | JP |
54-52312 | Apr 1979 | JP |
54-52313 | Apr 1979 | JP |
61155410 | Jul 1986 | JP |
63-11817 | Jan 1988 | JP |
01034840 | Feb 1989 | JP |
2-213354 | Aug 1990 | JP |
WO8000923 | Nov 1979 | WO |
WO8300049 | Jun 1982 | WO |
WO8403838 | Mar 1984 | WO |
Entry |
---|
CN 200680042508.1 filed Dec. 4, 2006 Office Action dated Apr. 6, 2010. |
CN 200680042508.1 filed Dec. 4, 2006 Office Action dated Sep. 18, 2009. |
EP 0683819.6 filed Dec. 4, 2006 Office Action dated Apr. 14, 2010. |
EP 0683819.6 filed Dec. 4, 2006 Office Action dated May 6, 2009. |
PCT/US2006/046216 filed Dec. 4, 2006 International Preliminary Report on Patentability dated Jun. 4, 2008. |
PCT/US2006/046216 filed Dec. 4, 2006 Search Report dated Jun. 6, 2007. |
PCT/US2006/046216 filed Dec. 4, 2006 Written Opinion dated Jun. 6, 2007. |
Uchiyama, Manabu et al, Nonlinear Buckling Simulations of Imperfect Shell Domes using a Hybrid Finite Element Formulation and the Agreement with Experiments, Fourth International Colloquium on Computation of Shell & Spatial Structures, 14 pages, Chania-Crete, Greece, Jun. 5-7, 2000. |
Zhiming, Ye, Nonlinear Analysis and Optimization of Shallow Shells of Variable Thickness, printed from http://www.shu.edu.cn/journal/vol1no2199705.htm. |
CA 2,626,335 filed Dec 4, 2006 Examiner's Report dated Aug. 13, 2012. |
CN 200680042508.1 filed Dec. 4, 2006 Office Action dated Mar. 29, 2012. |
Number | Date | Country | |
---|---|---|---|
20070161940 A1 | Jul 2007 | US |
Number | Date | Country | |
---|---|---|---|
60741578 | Dec 2005 | US |